An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
We have previously reported that estrogens have the potential to induce new forms of renin substrate in addition to elevating the major circulating form of this protein. One of these estrogen-induced forms had a molecular weight in excess of 150,000. In this study we have compared the plasma concentration of the high-molecular-weight renin substrate in normotensive women receiving estrogen therapy and women with estrogenic hypertension. A statistically significant elevation of this protein was associated with estrogenic hypertension and normotensive pregnant women at term. This form of renin substrate differed from the major form with respect to electrophoretic mobility, isoelectric point, and immunologic cross-reactivity. In addition, kinetic analysis indicated that this high-molecular-weight substrate has a significantly higher affinity for the enzyme renin than the major circulating form (Km = 1800 +/- 290 versus 3520 +/- 260 ng angiotensin I equivalents/ml). These results suggest that in addition to renin substrate concentration, substrate composition may play an important role in blood pressure regulation.
D000328:Adult; D000808:Angiotensinogen / Q000009:adverse effects / Q000097:blood* / Q000302:isolation & purification; D000809:Angiotensins / Q000097:blood*; D003276:Contraceptives, Oral / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008875:Middle Aged; D008970:Molecular Weight; D011247:Pregnancy; D013268:Stimulation, Chemical
D000809:Angiotensins; D003276:Contraceptives, Oral; D004967:Estrogens; D000808:Angiotensinogen